Skip to main content
Hide

Data analysis: Leveraging real-world lab data to reveal the hidden patient population 

Data analysis

Are gaps in traditional claims data stalling your clinical pipeline?

 

Relying on claims data alone leaves critical patient populations completely invisible. For drug discovery teams, leveraging real-world lab data is the key to uncovering the true addressable market. Accessing these deeper clinical insights gives your team the confidence needed to eliminate a nonviable target or consider moving it forward with development.

 

See how real-world lab data revealed a 170% larger population of suspected IgAN patients compared to claims data alone.

Data analysis: Leveraging real-world lab data to reveal the hidden patient population

See the value of 
real-world lab data

939

* indicates required